Here are five insights:
1. The new feature allows physicians to research prescription drugs by FDA-approved indications.
2. SERMO Drug Ratings already enabled physicians to share their prescription drugs’ reviews and ratings with each other.
3. Physicians rate the drugs based on efficacy, safety, tolerability, accessibility and adherence.
4. The addition allows physicians to compare different classes of drugs for specific conditions.
5. SERMO Drug Ratings includes 350,000 ratings and 23,000 comments. The tool encompasses more than 3,000 rated drugs.
More articles on practice management:
7 key points on the future of AAOS from new CEO Thomas Arend Jr.
Why medical practices need to maintain a positive online image
Dr. Jerome Adams confirmed as surgeon general — 6 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
